Newly obtained data from the New Zealand government reveals a disturbing 188% increase in 3-month mortality rates among 12- to 19-year-olds following COVID-19 vaccination.

The official data released by the New Zealand government (OIA HNZ00064867 released 22 October 2024) also revealed a statistically significant 83% increase in mortality rates among the 20- to 30-year-old age group.

This new data follows a previous Official Information Act (OIA) release showing a striking rise in Accident and Emergency visits for chest pain among people under 40. Cases have escalated from about 4,400 in 2020 to nearly 30,000 each year.

Despite the alarming trend in deaths and hospitalizations, Health New Zealand has not issued a public response, nor has the New Zealand media reported on these figures.

New Zealand’s relatively small population makes it an ideal test case for scientific studies, allowing researchers to gather data and analyze trends with greater clarity and precision.

In the 2021/22 period, New Zealand’s population of 5 million received approximately 12 million doses of COVID-19 vaccines. During this time, official records show a rise in all-cause mortality, coinciding with the vaccine rollout even though COVID-19 infections were minimal and flu cases were largely curbed by strict border closures.

All-cause deaths increased from 34,260 in 2019 (6.9 per 1,000 people) to 38,574 in 2022 (7.4 per 1,000), a jump of 7.8%. This trend has sparked concern, raising questions about broader health impacts.

Recently released data from an Official Information Act request gives new insight into which age groups may have experienced disproportionate excess mortality in the three months following COVID-19 vaccination during 2021 and 2022.

New Zealand Dr. Guy Hatchard analyzed the data and found that teenagers and young adults appear to be disproportionately affected by the mRNA vaccines.

Allowing for the vaccination coverage rate, over the two-year period the 12-19 age group as a whole were within 93 days of a covid-19 vaccination for just 9% of the time. Yet their 3-month deaths (67) accounted for 26% of the total number of deaths (254) in their age bracket over the two-year period. An increased mortality risk of 188%

The 20-30 age group as a whole were within 93 days of a covid-19 vaccination for 12% of the time over the 2 years. Yet their 3-month deaths (166) accounted for 22% of the total number of deaths (762) in their age bracket over the two-year period. That is an increased mortality risk of 83%.

The other age brackets covered by the OIA (30s, 40s, 50s, 60s and 71+) had a 3-month mortality risk relatively close to the elevated all-cause mortality risk for the period. None of these age groups had a disproportionately elevated mortality risk, merely the already mentioned excess death rate.

The data used in this analysis comes exclusively from OIAs and Official Health New Zealand and Stats New Zealand websites. Health New Zealand vaccination data is always published underneath the following legal disclaimer:

Data are sourced from the Aotearoa Immunisation Register (AIR) and may be subject to any data quality issues still to be resolved in AIR, which includes, but is not limited to: Incorrect vaccination event dates, miscoding of vaccination given, miscoded indication code and miscoding of person to vaccination event. Note that these data quality issues are largely attributed to the fact that many fields within AIR are free text and are therefore prone to data entry errors.

This information must be shared widely. The carefully constructed public relations narrative surrounding the safety and efficacy of COVID-19 vaccines needs to be dismantled, as it fails to align with the real-life health data from New Zealand. Ignoring the potential risks to children is simply unacceptable.